Skip to content
CompletedN/A

Ketamine IV Classic Protocol : Five Years Follow up

NCT04824157 · Sheba Medical Center

Closed to entry
Status
Not accepting participants
Not applicable
Phase
11
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Mood that will be evaluated using the MADRAS Montgomery-Asberg Depression Rating Scale".

    Measured over 6 months

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 80 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: * Patient who participated in ketamine study 1126 Exclusion Criteria: * None

Where

1 study site

FacilityCityRegionCountry
The Chaim Sheba Medical CenterTel LitwinskyIsrael

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT04824157 on ClinicalTrials.gov →

Last updated in the registry 2021-04-01. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits